Unitedhealth Group Inc

• UnitedHealth dropped due to rising medical utilization and compressed underwriting margins. • Regulatory scrutiny on Medicare Advantage and pharmacy benefits added sector-wide pressure. • The stock exhibits neutral technical indicators with an oversold Williams %R.

• Thermo Fisher faced downward pressure from macroeconomic challenges and life sciences headwinds. • Investors locked in gains following valuation consolidation and recent post-earnings strength. • Technical indicators show neutral conditions with an RSI value of 51.696.

• CVS Health showed upward momentum ahead of its third-quarter earnings release. • The stock trades at a discount to historical valuation multiples. • Annual revenue reached $402.07 billion with net profit at $1.77 billion.

• Abbott Laboratories reported positive clinical data for cardiovascular devices at a medical conference. • The company plans to separate its Nutrition segment into a standalone public entity by 2027. • Abbott recorded annual revenue of $44.33 billion and net profit of $6.52 billion.

• HCA reported strong third-quarter results exceeding Wall Street revenue and earnings expectations. • Management expects full-year operating performance in the upper half of guidance ranges. • Analysts reaffirmed favorable ratings and raised price targets following the earnings call.

• GE HealthCare reported Q3 results exceeding expectations and raised full-year guidance. • Total backlog reached record levels with significant revenue visibility and margin expansion. • Technical indicators show a MACD buy signal and an overbought RSI condition.